| Literature DB >> 32790362 |
Gerard Kian-Meng Goh1, A Keith Dunker2, James A Foster3,4, Vladimir N Uversky5,6.
Abstract
A model to predict the relative levels of respiratory and fecal-oral transmission potentials of coronaviruses (CoVs) by measuring the percentage of protein intrinsic disorder (PID) of the M (Membrane) and N (Nucleoprotein) proteins in their outer and inner shells, respectively, was built before the MERS-CoV outbreak. With MPID = 8.6% and NPID = 50.2%, the 2003 SARS-CoV falls into group B, which consists of CoVs with intermediate levels of both fecal-oral and respiratory transmission potentials. Further validation of the model came with MERS-CoV (MPID = 9%, NPID = 44%) and SARS-CoV-2 (MPID = 5.5%, NPID = 48%) falling into the groups C and B, respectively. Group C contains CoVs with higher fecal-oral but lower respiratory transmission potentials. Unlike SARS-CoV, SARS-CoV-2 with MPID = 5.5% has one of the hardest outer shells among CoVs. Because the hard shell is able to resist the antimicrobial enzymes in body fluids, the infected person is able to shed large quantities of viral particles via saliva and mucus, which could account for the higher contagiousness of SARS-COV-2. Further searches have found that high rigidity of the outer shell is characteristic for the CoVs of burrowing animals, such as rabbits (MPID = 5.6%) and pangolins (MPID = 5-6%), which are in contact with the buried feces. A closer inspection of pangolin-CoVs from 2017 to 2019 reveals that pangolins provided a unique window of opportunity for the entry of an attenuated SARS-CoV-2 precursor into the human population in 2017 or earlier, with the subsequent slow and silent spread as a mild cold that followed by its mutations into the current more virulent form. Evidence of this lies in both the genetic proximity of the pangolin-CoVs to SARS-CoV-2 (∼90%) and differences in N disorder. A 2017 pangolin-CoV strain shows evidence of higher levels of attenuation and higher fecal-oral transmission associated with lower human infectivity via having lower NPID (44.8%). Our shell disorder model predicts this to be a SARS-CoV-2 vaccine strain, as lower inner shell disorder is associated with the lesser virulence in a variety of viruses.Entities:
Keywords: COVID; antibody; attenuate; coronavirus; disorder; immune; intrinsic; matrix; nucleocapsid; nucleoprotein; pangolin; protein; shell; vaccine; virulence
Mesh:
Substances:
Year: 2020 PMID: 32790362 PMCID: PMC7640969 DOI: 10.1021/acs.jproteome.0c00460
Source DB: PubMed Journal: J Proteome Res ISSN: 1535-3893 Impact factor: 4.466
Categorization of Coronaviruses by Mainly N PID to Predict Levels of Respiratory and Fecal–Oral Transmission Potentials (p < 0.001, r2 = 0.8)
| coronavirus | accession:
UniProt (U), GenBank (G) (M proteins) | accession: UniProt
(U), GenBank (G) (N) | M PID | N PID | remarks | shell disorder/group |
|---|---|---|---|---|---|---|
| HCoV-229E | P15422 (U) | P15130 (U) | 23 | 56 | Higher levels of respiratory transmission lower levels of fecal–oral transmission | A |
| IBV (Avian) | P69606 (U) | Q8JMI6 (U) | 10 | 56 | ||
| Bovine | P69704 (U) | Q8V432 (U) | 7.8 | 53.1 | Intermediate levels of respiratory and fecal–oral transmission | B |
| Rabbit | H9AA37 (U) | H9AA59 (U) | 5.7 | 52.2 | ||
| PEDV (Porcine) | P59771 (U) | Q07499 (U) | 8 | 51 | ||
| Canine (Resp.) | A3E2F6 (U) | A3E2F7 (U) | 7 | 50.5 | ||
| HCoV-OC43 | Q4VID2 (U) | P33469 (U) | 7 | 51 | ||
| SARS-CoV | P59596 (U) | P59595 (U) | 8.6 | 50.2 | ||
| HCoV-NL63 | Q6Q1R9 (U) | Q6Q1R8 (U) | 11 | 49 | ||
| SARS-Cov-2 | P0DTC5 (U) | P0DTC9 (U) | 5.9 | 48.2 | ||
| Bats | A3EXD6 (U) | Q3LZX4 (U) | 11.2 ± 5.3 | 47.7 ± 0.9 | ||
| MHV (Murine) | Q9JEB4 (U) | P03416 (U) | 8 | 46.8 | Lower levels of respiratory transmission higher levels of fecal–oral transmission | C |
| Pangolin | QIA428617 (G) | QIA48630 (G) | 5.6 ± 0.9 | 46.6 ± 1.6 | ||
| MERS-CoV | K0BU37 (U) | K0BVN3 (U) | 9.1 | 44.3 | ||
| TGEV (Porcine) | P09175 (U) | P04134 (U) | 14 | 43 | ||
| Canine (Ent.) | B8RIR2 (U) | Q04700 (U) | 8 | 40 | ||
| HCoV-HKU1 | Q14EA7 (U) | Q0ZME3 (U) | 4.5 | 37.4 |
UniProt (U): https://www.uniProt.org); GenBank-NCBI (G): (https://www.ncbi.nlm.nih.gov/protein).
More details on the bat samples can be found in Table . Three out of four bat-CoVs are in group B. Note: Large standard deviation can be seen for N PID as denoted by “±”.
MHV sits at the borderline and is placed in group C for convenience.
More details on the pangolin samples can be found in Table . Three out of four bat-CoVs are in group C. Standard deviation is denoted by “±”.
Grouping of Pangolin-CoVs and Bat-CoVs by Mainly N PID with SARS-CoV and SARS-CoV-2 as References
| coronavirus | M PID (%) | accession: UniProt (U), GenBank (G) | sequence similarity (%) | N PID (%) | accession: UniProt (U), GenBank (G) | sequence similarity | group |
|---|---|---|---|---|---|---|---|
| SARS-CoV-2 | 5.9 | P0DTC5 (U) | 100 | 48.2 | P0DTC9 (U) | 100 | B |
| SARS-CoV | 8.6 | P59596 (U) | 90.5 | 50.24 | 56 | 90.5 | B |
| Civet-SARS-CoV | 8.6 | QZ3TE9 (U) | 90.1 | 90.01 | B | ||
| Pangolin-CoV | 5.6 ± 0.9 | 46.6 ± 1.6 | 53 | ||||
| 2019 | 6.3 | QIG55948 (G) | 98.2 | 48.7 | QIG55953 (G) | 98 | B |
| 2018 | 4.5 | QIQ54051 (G) | 97.7 | 46.3 | QIQ54056 (G) | 93.8 | C |
| QIA48617 (G) | QIA48630 | ||||||
| 46.5 | QIA48656 (G) | 93.32 | C | ||||
| Bat-CoV | 11.2 ± 15 | Q9JEB4 | 47.7 ± 0.9 | ||||
| RATG13 | 4.1 | QHR63303 (G) | 99.6 | 48.5 | QHR63308 (G) | 99.1 | B |
| 512 | 15.3 | Q0Q463 (U) | 35.5 | 46.5 | Q0Q462 (U) | 29.4 | C |
| HKU3 | 7.7 | Q3LZX9 (U) | 91 | 48 | Q3LZX4 (U) | 89.6 | B |
| HKU4 | 16.4 | A3EXA0 (U) | 42.7 | 48.5 | A3EXA1 (U) | 51.1 | B |
| HKU5 | 11.8 | A3EXD6 (U) | 44.7 | 47.1 | A3EXD7 (U) | 47.9 | B |
Standard deviation is denoted by “±”.
Possible vaccine strain for SARS-CoV-2 detected.
Figure 1N and M PIDs of the various CoVs. (A) M PID of the CoVs with lowest M PID found in the sample. (B) N PIDs of the CoVs with hardest outer shell (M). (C) N PIDs of pangolin-CoV with comparison to SARS-CoV-2 (SARS2) and 2003 SARS-CoV (SARS). Case-fatality rates (CFR) of SARS-CoV and SARS-CoV-2 are added in C. Civet-SARS-CoV and MERS-CoV were shown in B only as references. Pangolin-CoV 2017(**) has been identified as a possible vaccine strain.
Figure 2Phylogenetic trees of CoV N and M with disorder (PID) annotations. (A) M Phylogenetic tree. (B) N Phylogenetic tree. Pangolin-CoV strains can be cross-referenced and identified using the respective N PIDs or M PIDs in Table .
Figure 3Possible pathways of SARS-CoV/SARS-CoV-2 and its precursors in various animals. (A) Civet cats and SAR-CoV. (B) Pangolins and SARS-CoV-2, Path B, where the CoV did not have a chance to evolve with the pangolins. (C) Pangolins and SARS-CoV-2, Path C, where the CoV has evolved with pangolins for a long time. (D) Rabbits and SARS-CoV-2 (hypothetical purpose only). (E) Bovine and SARS-CoV-2 (hypothetical purpose only). The timeline for each pathway is adjusted for the evolutionary pressures seen in the shell disorder model. Paths A and C are highly plausible on the basis of phylogenetic and shell disorder models.